WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features
WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508546933/en/
WHOOP Unveils Next Generation WHOOP® 5.0 and WHOOP® MG
These innovations arrive at a pivotal moment when ailing health systems cost more and deliver less. WHOOP is advancing a new solution and a better way - one that empowers people to connect their daily decisions to performance and health outcomes that can be measured and felt. While others track surface-level trends, WHOOP delivers longevity through depth — translating the body’s most vital signals into guidance that extends healthspan, not just lifespan.
“This isn’t just a product launch. It’s a new chapter for WHOOP and for our members,” said Will Ahmed, WHOOP Founder & CEO. “We’ve taken everything we’ve learned over the past decade and built a platform to help our members perform and live at their peak for longer. We’ve held nothing back.”
Imagery of WHOOP 5.0 and WHOOP MG here.
NEW HEALTH AND PERFORMANCE IN-APP FEATURES:
- Healthspan with WHOOP Age1: Get insights and guidance on how your daily habits impact your long-term health with Healthspan - a powerful new way to quantify your physiological age and slow your Pace of Aging. Developed in partnership with Dr. Eric Verdin, CEO of the Buck Institute for Research on Aging, Healthspan uses nine different metrics linked to long-term health to calculate your WHOOP Age and Pace of Aging.
- Heart Screener with ECG2: Your heart, in your hands. WHOOP now includes an FDA-cleared ECG feature that allows a reading to be taken anytime, from your wrist — and shared directly with a healthcare provider. The Heart Screener detects signs of Atrial Fibrillation (Afib)3, a leading cause of stroke, and provides Irregular Heart Rhythm Notifications4 (IHRN) for greater peace of mind.
- Blood Pressure Insights5: A patent-pending technology that delivers daily blood pressure insights, right from your wrist. Get estimated systolic and diastolic readings, and learn about how blood pressure affects wellbeing and performance.
- Women’s Hormonal Insights6: WHOOP goes beyond cycle tracking to deliver science-backed education and personalized insights on how hormonal shifts influence recovery, sleep, stress and performance. Whether you’re navigating menstruation, pregnancy, or perimenopause — WHOOP adapts with you.
- Sleep Performance Update: Unlock better nights and better days. The reimagined Sleep Score delivers a more accurate reflection of sleep quality, helping members recover more effectively and show up stronger each day.
- WHOOP Advanced Labs7: Join the waitlist for the next evolution in personalized health. Coming soon, WHOOP Advanced Labs will allow members to schedule blood tests and receive clinician reports that are integrated directly into the WHOOP app, creating a more comprehensive picture of your health — and giving you actionable steps to improve it.
- Comprehensive Fitness Tracking: From daily steps and VO₂ Max to Muscular Strain during strength training and 145+ supported activities, members can now optimize fitness for both performance and long-term health outcomes.
HARDWARE, REIMAGINED FOR PERFORMANCE AND PRECISION:
- Precision Sensors. Smaller Design. Greater Power: WHOOP 5.0 and MG pack more technology into a seven percent smaller form factor. Enhanced sensors capture data 26 times per second, while a redesigned processor delivers 10x more power efficiency — enabling richer insights without sacrificing battery life or comfort.
- 14+ Day Battery Life. New Wireless PowerPack8: 14+ days per charge across WHOOP 5.0 and MG hardware. Now, members with their device alongside the new Wireless Powerpack have access to a full month of battery life.
- Elevated Accessories: Complete the experience with a new line of WHOOP accessories — including the new LeatherLuxe, crafted from genuine Italian leather for our most premium look and feel yet.
- 24/7 Wearability: WHOOP remains the only wearable that’s truly wearable — designed for 24/7 use across multiple locations on the body. Powered by WHOOP Body and AnyWear™ technology, our technical garments seamlessly integrate with your device to capture data with unmatched precision — no matter your sport, lifestyle or movement.
- Medical-Grade ECG: Available exclusively on WHOOP MG, maintain peace of mind with medical-grade ECG readings you can do from the comfort of home. Simply place your thumb and index finger on the ECG-conductive clasp, and get a medical-grade reading in seconds.
CHOOSE YOUR EXPERIENCE:
To make these innovations even more accessible, WHOOP is also introducing three new membership tiers. These tiers empower WHOOP members to choose the hardware device, features and pricing that make the most sense for them:
- WHOOP One: Professional-grade fitness insights at our best price at $199 per year
- WHOOP Peak: Advanced health, fitness and longevity insights designed to help you perform at your peak, longer. Priced at $239 per year
- WHOOP Life: The most powerful WHOOP ever, delivering medical-grade health and performance insights. Priced at $359 per year
See below for global pricing.
“WHOOP is a great tool. It's like a doctor on my wrist,” said Cristiano Ronaldo, Professional Soccer Player and WHOOP Global Ambassador and Investor. “It allows me to monitor my behavior easily, and shows me that being consistent and prioritizing your health is worth it. I’m happy to be part of this company, and the launch of the WHOOP 5.0 and MG.”
WHOOP 5.0 and MG are available to purchase now on WHOOP.com.
Global Pricing
CURRENCY | ONE | PEAK | LIFE |
USD | 199 | 239 | 359 |
CAD | 259 | 349 | 529 |
EUR | 199 | 264 | 399 |
GBP | 169 | 229 | 349 |
AUD | 299 | 419 | 629 |
NZD | 359 | 489 | 739 |
AED | 699 | 919 | 1379 |
SAR | 799 | 1029 | 1549 |
QAR | 699 | 879 | 1319 |
About WHOOP
WHOOP, the human performance company, offers a wearable health and fitness coach to help people achieve their goals. The WHOOP membership provides best-in-class wearable technology, actionable feedback, and recommendations across recovery, sleep, training, and health. WHOOP 5.0 and WHOOP MG offer groundbreaking health innovations, including cardiovascular health features; Healthspan which quantifies Pace of Aging and provides members with their WHOOP Age; and first-of-its-kind wearable Blood Pressure Insights. WHOOP is the perfect health companion for anyone looking to optimize their health and performance. Founded in 2012, WHOOP is based in Boston and has raised more than $400 million in venture capital. WHOOP is available to ship in 56 markets worldwide and the WHOOP app is available in English, French, German, Italian and Spanish (Latin America). WHOOP can be purchased on Amazon across the U.S., U.K., and Australia, as well as Best Buy (U.S.) Dick’s Sporting Goods (U.S.), Flipkart (India) and Virgin Megastore (GCC), and more.
To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.
_________________________________ |
1This feature is not available for users under the age of 18. |
2This feature is not intended for users with known arrhythmias other than AFib or users under 22 years old. It is not recommended for users with a cardiac pacemaker, ICDs or other implanted electronic devices. This is a medically regulated feature and is not currently available in every region. |
4This feature is not intended for users with known atrial fibrillation or users under 22 years old. This is a medically regulated feature and is not currently available in every region. |
5Blood Pressure Monitor is not a medical device and cannot diagnose or manage medical conditions. It does not provide medical advice. Always consult your doctor for health concerns and never delay or modify medical care based on its information. |
6Menstrual Cycle Insights should not be used for birth control or fertility tracking. The ovulatory phase indicators are estimates only. Menstrual Cycle Insights is not a medical device and cannot diagnose or manage medical conditions. It does not provide medical advice. Always consult your doctor for health concerns and never delay or modify medical care based on its information. |
7USA only at launch. |
8Wireless PowerPack is offered with Peak & Life Memberships. Wired battery pack available on One. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250508546933/en/
Contacts
Sophie Holt
Jack Taylor PR
whoop@jacktaylorpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial 3-axis accelerometer has high offset stability24.6.2025 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has introduced a 3-axis accelerometer for the industrial market that combines high offset stability over temperature and time, good linearity, low noise density, and excellent robustness. The SCA3400-D01 XYZ accelerometer is meant for use in industrial applications such as structural health monitoring (SHM), machine control, inertial measurement units, and construction tools and systems. This product will be exhibited at Sensors Converge 2025 to be held at the Santa Clara Convention Center (Booth #716), California from 24 to 26 June 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623994075/en/ [Murata Manufacturing Co., Ltd.] Industrial 3-axis accelerometer The offset stability of an accelerometer refers to the consistency of its output when at rest, but subject to varying temperatures or the effects of aging. Ideally, this output should be zero, but i
Grid Dynamics Announces AI-Powered Engagement Model Enabling Accelerated Business Transformation for Fortune 1000 Enterprises23.6.2025 16:15:00 EEST | Press release
Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a prominent technology consulting and digital services provider specializing in AI, platform and product engineering, and digital engagement services—today announced the launch of an innovative AI-powered engagement model for its software engineering services. This new model is specifically engineered to deliver the next level of agility, quality, and accelerated time-to-market for Fortune 1000 enterprises. Grid Dynamics' innovative approach expands its engagement offerings beyond traditional Fixed Price, Time and Materials, and Capacity-based engagements. Key features include: Prompt-driven incremental output: Delivering value through iterative, prompt-guided development. Credit-based service consumption: Pricing aligned with desired outputs rather than effort—offering cost efficiency. AI-benchmarked code quality: Continuous evaluation against industry and client standards—ensuring code quality. Centralized client portal: A s
Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges23.6.2025 15:05:00 EEST | Press release
As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper examining the opportunities and challenges shaping this fast-evolving landscape of therapeutic class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623205345/en/ LBPs, which harness live microorganisms to restore or modulate human health, are being explored across a growing range of indications, from gastrointestinal and metabolic disorders to CNS and oncology. FDA approvals of Rebyota™ and Vowst™ have validated the category but for most biotech sponsors, the journey remains uncertain. According to Novotech’s analysis, over 90% of LBP assets are still in early development stages, and nearly one-third of all trials from 2020 to 2025 have been withdrawn or suspended due to regulatory, manufacturing, or design complexities. Highli
Sagemcom’s Net Zero Trajectory Approved by SBTi: Target Set for 204023.6.2025 15:00:00 EEST | Press release
Sagemcom Group has today reached a critical milestone in its climate strategy: its Net Zero carbon target for 2040—encompassing all activities and sites within the Group’s consolidated scope—has been officially validated by the Science Based Targets initiative (SBTi). This international endorsement attests to the scientific rigor of Sagemcom’s decarbonization strategy, aligned with the Paris Agreement’s ambition to limit global warming to 1.5°C. It strengthens the Group’s comprehensive climate roadmap, which is built on a significant reduction of greenhouse gas emissions across all scopes: By 2030: A 47% absolute reduction in Scope 1 and Scope 2 emissions (direct emissions and purchased energy), 100% renewable energy consumption across all Group sites, A 31% absolute reduction in Scope 3 emissions, including those related to the value chain, with no exclusion of any greenhouse gas categories. By 2040: Achievement of Net Zero, corresponding to a 90% absolute reduction in total Group emi
One, Two, Three-Peat: Mary Kay Inc. Named #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World for Three Years in a Row23.6.2025 15:00:00 EEST | Press release
Good things come in threes: iconic beauty brand and global entrepreneurship company Mary Kay Inc. has again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International for the third consecutive year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623000452/en/ Ryan Rogers, Chief Executive Officer of Mary Kay states: "Being named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International three years in a row marks a grand slam achievement for Mary Kay. This repeated milestone reflects years of R&D and marketing efforts to create skin and beauty solutions that meet consumer needs and are loved the world-over. Above all, it demonstrates the transformative power of our Independent Beauty Consultants who are driving this success globally." (Photo Courtesy: Mary Kay Inc.) Euromonitor International is the foremost provider of globa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom